Showing results (1-10 of 3,436) with videos related to
Sort By:
Pageof 344
Frontiers in Molecular Biosciences|July 26, 2021
Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in GliomaZaoqu Liu, Taoyuan Lu, Libo Wang, et al.International Immunopharmacology|November 18, 2021
Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinomaZaoqu Liu, Long Liu, ChunGuang Guo, et al.Journal of Oncology|February 8, 2021
Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical ManagementZaoqu Liu, Long Liu, Taoyuan Lu, et al.Frontiers in Oncology|September 27, 2021
Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular CarcinomaYuyuan Zhang, Zaoqu Liu, Xin Li, et al.Iscience|February 9, 2023
Exploring the roles of intestinal flora in enhanced recovery after surgeryZaoqu Liu, Na Li, Qin Dang, et al.Frontiers in Oncology|March 19, 2021
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular CarcinomaZaoqu Liu, Libo Wang, Long Liu, et al.Oncotargets and Therapy|July 15, 2021
A Comparative Study of Self-Expandable Metallic Stent Combined with Double 125I Seeds Strands or Single 125I Seeds Strand in the Treatment of Advanced Perihilar Cholangiocarcinoma with Malignant Obstructive JaundiceZhaonan Li, Dechao Jiao, Xinwei Han, et al.Journal of Cellular and Molecular Medicine|February 24, 2021
TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancerZaoqu Liu, Libo Wang, Chunguang Guo, et al.Frontiers in Genetics|June 3, 2021
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal AdenocarcinomaZaoqu Liu, Long Liu, Dechao Jiao, et al.Cellular Signalling|July 19, 2023
Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacyLibo Wang, Deshuang Fu, Siyuan Weng, et al.Pageof 344